News from the catapult network

News headlines from across the Catapult Network. For comprehensive news updates, please explore our Politics Home webpage or visit individual Catapult websites

Graphic of four images including a microscope, a solar panel, a man examining a samply and a flying drone
Catapult Network
NEWS
Catapulting growth in 2023 and beyond
In the face of many challenges – changing customer desires, cost pressures, supply chain disruption, expected regulatory changes and fierce competition – UK innovation is on the rise. This article showcases how Catapults helped to deliver great results for business and industry in 2023; it summarises our predictions for technology-driven advances in 2024 and the years ahead.
Read more
Cell and Gene Therapy
alt=
News
Cell and Gene Therapy Catapult and UCL Researcher-in-Residence to develop a digital twin of CAR-T manufacturing
A new Researcher-in-Residence partnership between the Cell and Gene Therapy Catapult, an independent innovation and technology organisation specialising in the advancement of the cell and gene therapy industry, and Associate Professor Stephen Goldrick from University College London (UCL), will develop a digital twin and build advanced process models of a key step in the CAR-T manufacturing process.
Read more
Cell and Gene Therapy
News
Cell and Gene Therapy Catapult and UCL Researcher-in-Residence to develop a digital twin of CAR-T manufacturing
A new Researcher-in-Residence partnership between the Cell and Gene Therapy Catapult, an independent innovation and technology organisation specialising in the advancement of the cell and gene therapy industry, and Associate Professor Stephen Goldrick from University College London (UCL), will develop a digital twin and build advanced process models of a key step in the CAR-T manufacturing process.
Read more
Cell and Gene Therapy
Scientists working in a lab
News
Cell and gene therapy industry continues to expand manufacturing infrastructure in the UK
The Cell and Gene Therapy Catapult, an independent innovation and technology organisation committed to the advancement of cell and gene therapies has released its Good Manufacturing Practice (GMP) Report 2024. It highlights continued growth in manufacturing infrastructure for advanced therapies, with 32 MHRA-licensed GMP manufacturing facilities in the UK, an increase from 28 last year.
Read more